CAS 914361-45-8
:Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Foram encontrados 10 produtos.
Fosravuconazole L-lysine ethanolate
CAS:Fosravuconazole L-lysine ethanolate
Pureza:≥95%Peso molecular:739.7g/molRef: 54-BUP05735
2mgA consultar5mgA consultar10mgA consultar25mgA consultar50mgA consultar100mgA consultarFosravuconazole L-lysine ethanolate
CAS:Fosravuconazole L-lysine ethanolateFórmula:C23H20F2N5O5PS·C6H14N2O2·C2H6OPeso molecular:739.734Fosravuconazole L-lysine ethanolate
CAS:Fosravuconazole L-lysine ethanolate, a prodrug for ravuconazole, treats onychomycosis in Japan.Fórmula:C31H40F2N7O8PSPureza:99.43%Cor e Forma:Yellow SolidPeso molecular:739.7Fosravuconazole L-lysine ethanolate
CAS:(S)-2,6-Diaminohexanoic acid (((2R,3R)-3-(4-(4-cyanophenyl)thiazol-2-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-yl)oxy)methyl dihydrogen phosphate and ethanol saltFórmula:C31H40F2N7O8PSPureza:97%Peso molecular:739.73Fosravuconazole L-Lysine Ethanolate-D₄
CAS:Produto ControladoFórmula:C23H16D4F2N5O5PS·C6H14N2O2·C2H6OCor e Forma:NeatPeso molecular:743.8Fosravuconazole L-lysine ethanolate
CAS:Fosravuconazole L-lysine ethanolate is an antifungal prodrug, which is a derivative of the widely used antifungal agent ravuconazole. This compound is synthesized through chemical modification to enhance its bioavailability and aqueous solubility, addressing limitations found in its parent compound. Fosravuconazole is designed to undergo in vivo conversion to ravuconazole, its active form, by enzymatic processes within the body.
Fórmula:C31H40F2N7O8PSPureza:Min. 95%Peso molecular:739.7 g/molFosravuconazole L-Lysine Ethanolate
CAS:Fórmula:C23H20F2N5O5PSC6H14N2O2C2H6OPeso molecular:547.47 : 146.2 : 46.1
